INVO Bioscience, Inc. (INVO) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 43 transactions totaling $961.1K, demonstrating a bullish sentiment with $961.1K in net insider flow. The most recent transaction on Jun 1, 2022 involved a purchase of 177,306 shares valued at $168.4K.
No significant insider buying has been recorded for INVO in the recent period.
No significant insider selling has been recorded for INVO in the recent period.
Based on recent SEC filings, insider sentiment for INVO is bullish with an Insider Alignment Score of 100/100 and a net flow of $961.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at INVO Bioscience, Inc. (INVO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading INVO stock, having executed 43 transactions in the past 90 days. The most active insider is Investment Company, Inc. Awm (Executive), who has made 14 transactions totaling $424.2K.
Get notified when executives and directors at INVO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Doody Kevin | Executive | Purchase | 177,306 | $0.95 | $168.4K | |
| Jun 1, 2022 | Messina Rebecca | Executive | Purchase | 9,868 | $0.95 | $9.4K | |
| Jun 1, 2022 | Goren Andrea | Executive | Purchase | 52,632 | $0.95 | $50.0K | |
| Jun 1, 2022 | Jos. Campbell Michael | Executive | Purchase | 10,526 | $0.95 | $10.0K | |
| Jun 1, 2022 | Segal Jeffrey | Executive | Purchase | 9,211 | $0.95 | $8.8K | |
| Jun 1, 2022 | D. Davis Trent | Executive | Purchase | 11,184 | $0.95 | $10.6K | |
| Jun 1, 2022 | K. Szot Matthew | Executive | Purchase | 14,474 | $0.95 | $13.8K | |
| Jun 1, 2022 | Ryan Barbara | Executive | Purchase | 10,526 | $0.95 | $10.0K | |
| Jun 1, 2022 | Shum Steve | Executive | Purchase | 58,885 | $0.95 | $55.9K | |
| Jan 15, 2022 | Goren Andrea | Executive | Award | 5,361 | $N/A | $0 | |
| Jan 15, 2022 | Ryan Barbara | Executive | Award | 8,588 | $N/A | $0 | |
| Jan 15, 2022 | Messina Rebecca | Executive | Award | 8,311 | $N/A | $0 | |
| Jan 15, 2022 | K. Szot Matthew | Executive | Award | 10,250 | $N/A | $0 | |
| Jan 15, 2022 | Shum Steve | Executive | Award | 20,111 | $N/A | $0 | |
| Jan 15, 2022 | Jos. Campbell Michael | Executive | Award | 15,236 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 25 | $961.1K | 100.0% |
Award(A) | 18 | $0 | 0.0% |
Insiders at INVO Bioscience, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 43 transactions totaling $961.1K in purchases versus $0 in sales, the net buying activity of $961.1K signals strong executive confidence. Investment Company, Inc. Awm (Executive) leads the buying activity with $424.2K in transactions across all time.